Panvac-F
Trademark details
Panvac-F® is a registered trademark used for Poxvius Based Cancer Vaccines and Recombinant Poxviruses Used To Prepare Vaccines and Biological Immunogens For Use In the Treatment of Cancer and owned by Therion Biologics Corporation. Full trade mark registration details, registered images and more information below.
| Goods and/or Services: | Poxvius Based Cancer Vaccines and Recombinant Poxviruses Used To Prepare Vaccines and Biological Immunogens For Use In the Treatment of Cancer |
| Serial Number: | 76597554 |
| Registration Number: | 2980687 |
| Filing Date: | Jun 14, 2004 |
|
Last Applicant(s)/ Owner(s) of Record | Therion Biologics Corporation222 Third Street, Suite 2300 |
| Related Products: | Pharmaceuticals |
Web Sites
powered by 
Total : 475 View more »
CCR Clinical Trials at NIH: Patients and General Public: Clinical ...
Additional Information: This trial will be conducted at the NIH Clinical Center in Bethesda, MD. It is open to patients who meet the eligibility requirements ...
Vaccine Therapy and GM-CSF in Treating Patients With Locally ...
To determine the tolerability of delivering two standard doses of intratumoral recombinant fowlpox PANVAC vaccine (PANVAC-F; falimarev) when administered in combination ...
PANVAC-V and PANVAC-F Vaccines Plus Sargramostim to Treat Advanced ...
Background: Many cancers produce two proteins, carcinoembryonic antigen (CEA) and mucin-1 (MUC-1). The PANVAC-V priming vaccine and PANVAC-F boosting vaccine contain ...
A pilot study of a PANVAC-V and PANVAC-F in patients (pts) with ...
Home > Meetings > Abstracts ... The Remember Me feature is an automatic login process which creates a cookie on the hard drive of your computer containing a unique ...
